Gisborne Hospital Report - Health and Disability Commissioner
Gisborne Hospital Report - Health and Disability Commissioner
Gisborne Hospital Report - Health and Disability Commissioner
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Gisborne</strong> <strong>Hospital</strong> 1999 – 2000<br />
PSA Testing Procedures<br />
mortuary, in the absence of a cytotechnologist <strong>and</strong> anatomical<br />
pathologist.<br />
The technician in charge of the Clinical Biochemistry left the laboratory<br />
in March 2000.<br />
The laboratory manager had attempted to address some of the issues in<br />
relation to staffing with limited success.<br />
[<strong>Hospital</strong>] management had proposed <strong>and</strong> explored alternative<br />
structures, associations, alliances, tendering of services <strong>and</strong> management<br />
contracts. The preferred option was still under consideration, <strong>and</strong> as<br />
such, outst<strong>and</strong>ing issues have not been addressed. [At the time of<br />
writing this report the laboratory is still managed by Tairawhiti<br />
<strong>Health</strong>care.]<br />
The laboratory <strong>and</strong> [<strong>Hospital</strong>] management need to identify <strong>and</strong><br />
comprehensively address all matters of concern in relation to<br />
management <strong>and</strong> operation of testing services, including those corrective<br />
action issues identified in this report.<br />
The primary issues raised in this report relate to performance with<br />
internal <strong>and</strong> external quality control activity. There was no evidence that<br />
biased <strong>and</strong> out-of-limit values in either internal or external quality<br />
control activities were recognised, or that corrective action was taken.<br />
These matters are similar to the issues that resulted in the previous<br />
suspension of Clinical Biochemistry [in 1998].<br />
The large bias in some analytes may affect clinical interpretation.<br />
The assessment team informed the laboratory that it had made a<br />
recommendation to the Chief Executive Officer of International<br />
Accreditation New Zeal<strong>and</strong> that the accreditation of Clinical<br />
Biochemistry should be suspended. Following a review on Wednesday<br />
19 July 2000, the suspension of Clinical Biochemistry will be confirmed.<br />
The laboratory will need to confirm that at least all identified items <strong>and</strong><br />
areas of concern have been satisfactorily addressed before reinstatement<br />
may be considered. International Accreditation New Zeal<strong>and</strong> in<br />
conjunction with an assessment team, will need to complete a follow-up<br />
assessment to confirm implementation of effective corrective action<br />
measures.”<br />
The nine other corrective action requests focused on management of<br />
laboratory staff, training of laboratory staff, laboratory quality control<br />
procedures, procurement of consumables, review of new work, corrective<br />
action procedures, control of non-conforming work, technical records, quality<br />
records, equipment, test methods <strong>and</strong> procedures, <strong>and</strong> internal audits.<br />
The Project Plan “Quality 2000”<br />
155